Patents by Inventor Taede RISPENS

Taede RISPENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF
    Publication number: 20240336676
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: October 16, 2023
    Publication date: October 10, 2024
    Inventors: Scott Lauder, Tom Purcell, Sridhar Govindarajan, Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw, Taede Rispens, Ilse Jongerius, Gillian Dekkers
  • Factor H potentiating antibodies and uses thereof
    Patent number: 11820814
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: November 21, 2023
    Assignees: GEMINI THERAPEUTICS SUB, INC., STICHTING SANQUIN BLOEDVOORZIENING
    Inventors: Scott Lauder, Tom Purcell, Sridhar Govindarajan, Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw, Taede Rispens, Ilse Jongerius, Gillian Dekkers
  • FACTOR H POTENTIATING ANTIBODIES AND USES THEREOF
    Publication number: 20220372120
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 24, 2022
    Inventors: Scott LAUDER, Tom PURCELL, Sridhar GOVINDARAJAN, Taco Willem KUIJPERS, Diana WOUTERS, Maria Clara BROUWER, Richard Benjamin POUW, Taede RISPENS, Ilse JONGERIUS, Gillian DEKKERS
  • METHODS AND COMPOUNDS FOR TYPING RHEUMATOID FACTORS
    Publication number: 20220244252
    Abstract: The invention relates to methods for typing rheumatoid factor comprising contacting a sample from a subject with at least one compound comprising a recombinant human IgG class fragment crystallizable (Fc) domain comprising first and second rheumatoid factor epitopes, to such compounds that can be used in the methods and to uses thereof.
    Type: Application
    Filed: June 5, 2020
    Publication date: August 4, 2022
    Inventors: Taede RISPENS, Willem Jan Julius FALKENBURG, Gerrit Jan WOLBINK, Dirkjan VAN SCHAARDENBURG